Epinephrine, inodilator, or no inotrope in venoarterial extracorporeal membrane oxygenation implantation: a single-center experience.
Viviane ZotzmannJonathan RilingerCorinna N LangKlaus KaierChristoph BenkDaniel DuerschmiedPaul M BieverChristoph BodeTobias WengenmayerDawid L StaudacherPublished in: Critical care (London, England) (2019)
Early epinephrine therapy within the first 24 h after cannulation for VA-ECMO was associated with poor survival compared to patients with or without any inodilator therapy. Until randomized data are available, epinephrine should be avoided in patients on VA-ECMO.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- respiratory failure
- end stage renal disease
- ejection fraction
- chronic kidney disease
- mechanical ventilation
- double blind
- prognostic factors
- big data
- electronic health record
- intensive care unit
- placebo controlled
- machine learning
- phase iii
- study protocol
- bone marrow